|
Market Cap (24-Jun) $646,684,416 (796th) |
Close (30-Jun) $0.330 |
Volume (30-Jun) 147,149 |
Shortsold (26-May) 152,126 (0.04%) (509th) |
|
52w High $2.25 |
52w Low $1.15 |
P/E - |
EPS -0.11 |
IMR released this announcement to the ASX on 27 October 2022, 8:27. The announcement is not marked as price sensitive, and is 15 page(s) in length and 1.27MB in size.
You can view all announcements from IMR and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMR was 0.081% short sold according to ASIC data. It was ranked the 501st most shorted stock on the ASX. It remains ranked 509th as of the latest reported data (26 May 2026).
| Other Recent Announcements from IMR | |
|---|---|
| Notification of cessation of securities - IMR | 9 June 2023, 11:34 |
| Appendix 3Y - SW | 7 June 2023, 11:12 |
| Notification regarding unquoted securities - IMR | 6 June 2023, 9:36 |
| Investor Presentation | 27 October 2022, 8:27 |
| Imricor Q3 FY22 Quarterley Activities Report and Appendix 4C | 27 October 2022, 8:26 |
| U.S. Restriction On CHESS Depository Interests Removed | 25 October 2022, 8:55 |
| Details of Q3 Appendix 4C Investor Webinar | 24 October 2022, 8:19 |
You must be logged in to post a reply.
Imricor Medical Systems, Inc 